StackTerminal.Health

BETA

Research-only: Mito / Fatigue / Readiness (SS-31 + MOTS-C)

B84· Mostly solid
Public 06 Feb 2026

Mitochondria-oriented peptide grouping. SS-31 has clinical trials in specific mitochondrial diseases; MOTS-C is mostly preclinical.

Research-only: Mito / Fatigue / Readiness (SS-31 + MOTS-C)
SS-31 (Elamipretide)
PLACEHOLDER
MODERATE
1mg
MOTS-C
PLACEHOLDER
MODERATE
1mg
No interactions detected
Each dose includes evidence rationale · doses personalized to your weight
AI risk assessment
Context: No wearable data
PROAI risk assessment is available with Pro.
See plans
Supplements
2 items
PLACEHOLDER · Lyophilized
Exercise performance (short-term, earlier phase 2 dose-escalation)Efficacy & safety — phase 3 primary endpoints not met

Clinical data exists in mitochondrial myopathy (endpoint-dependent).

1mg
PLACEHOLDER · Other
Running performance under metabolic stressClinical translation statusExercise/metabolic signaling (summary)

Mostly preclinical metabolic/exercise signaling; limited established human efficacy evidence.

1mg
Similar community stacks
Browse all →
gutdigestionresearch-only

Groups gut-inflammation oriented peptides (mostly studied in preclinical colitis/inflammation models).

KPV
1mg
BPC-157
1mg
Magnesium (Glycinate)
400mg
New
View
recoveryskinresearch-only

Adds a copper peptide often discussed in cosmetic/skin contexts to a recovery/joint pairing. Evidence is indirect & component-based.

BPC-157
1mg
TB500 (TB4 / Thymosin Beta-4)
1mg
GHK-Cu
1mg
New
View
endurancefatiguecaffeine-free

Targets perceived fatigue without stimulant reliance.

Rhodiola Rosea
400mg
New
View
Community Insights
My notes
Sign in to keep a private note on Research-only: Mito / Fatigue / Readiness (SS-31 + MOTS-C).